DEA Schedule CIII
Strength
20 ug/h
Manufacturer
Alvogen Inc.NDC
47781040804
Classification
Generic
Dosage Form
PATCH, EXTENDED RELEASE
Route
TRANSDERMAL
Last Updated
4/22/2026
Active Ingredients
BUPRENORPHINEApproval Type
Generic (ANDA)
FDA Application
ANDA207490On Market Since
5/17/2022
Pharmacological Classes
Partial Opioid Agonist
Partial Opioid Agonists
Related Drugs
Same classification
BUPRENORPHINE 2 MG TABLET SL
Generic
00054017613•Hikma Pharmaceuticals USA Inc.
$0.2676
per EA
BUPRENORPHINE 2 MG TABLET SL
Generic
00121101930•PAI Holdings LLC
$0.2676
per EA
BUPRENORPHINE 2 MG TABLET SL
Generic
00228315603•Actavis Pharma, Inc.
$0.2676
per EA
BUPRENORPHINE 2 MG TABLET SL
Generic
00904715404•Major Pharmaceuticals
$0.2676
per EA
BUPRENORPHINE 2 MG TABLET SL
Generic
42858050103•Rhodes Pharmaceuticals L.P.
$0.2676
per EA
BUPRENORPHINE 2 MG TABLET SL
Generic
50268012815•AvPAK
$0.2676
per EA
BUPRENORPHINE 2 MG TABLET SL
Generic
60687048121•American Health Packaging
$0.2676
per EA
BUPRENORPHINE 2 MG TABLET SL
Generic
62756045983•Sun Pharmaceutical Industries Inc.
$0.2676
per EA
BUPRENORPHINE 2 MG TABLET SL
Generic
72888018230•Advagen Pharma Ltd.
$0.2676
per EA
BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET
Generic
00054018813•Hikma Pharmaceuticals USA Inc.
$0.4698
per EA